CD36 high cells displayed elevated expression of CPT1A, and in contrast with the study described above, treatment with the CPT1A inhibitor etomoxir suppressed FAO in MAPKi treated melanoma cells [68]. The gene discussed is CPT1A; the disease is melanoma.